O'Donnell, A. et al. (2005) A phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points. British Journal of Cancer, 93(8), pp. 876-883.
Full text not currently available from Enlighten.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Leach, Dr Michael |
| Authors: | O'Donnell, A., Padhani, A., Hayes, C., Kakkar, A., Leach, M., Trigo, J., Scurr, M., Raynaud, F., Phillips, S., Aherne, W., Hardcastle, A., Workman, P., Hannah, A., and Judson, I. |
| College/School: | College of Medical Veterinary and Life Sciences |
| Journal Name: | British Journal of Cancer |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details